Papakostas, George I <br/><br/>
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.  [electronic resource] 

 -  The Journal of clinical psychiatry  Dec 2012 
 - 1541-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-2101 
<br/><br/><label>Standard No.: </label>10.4088/JCP.12m07670  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Depressive Disorder, Major--diagnosis<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Personality Inventory--statistics & numerical data<br/>Piperazines--adverse effects<br/>Psychometrics<br/>Thiazoles--adverse effects